Chemoinformaics analysis of Estra-1,3,5(10)-trien-17.beta.-ol
| Molecular Weight | 256.389 | nRot | 0 |
| Heavy Atom Molecular Weight | 232.197 | nRig | 20 |
| Exact Molecular Weight | 256.183 | nRing | 4 |
| Solubility: LogS | -4.891 | nHRing | 0 |
| Solubility: LogP | 4.186 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 46.865 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.746 |
| Synth | 3.394 |
| Natural Product Likeliness | 1.783 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.082 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.72 |
| MDCK | 0.0000256 |
| BBB | 0.532 |
| PPB | 0.965148 |
| VDSS | 1.527 |
| FU | 0.0169372 |
| CYP1A2-inh | 0.298 |
| CYP1A2-sub | 0.754 |
| CYP2c19-inh | 0.18 |
| CYP2c19-sub | 0.774 |
| CYP2c9-inh | 0.292 |
| CYP2c9-sub | 0.738 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.894 |
| CYP3a4-inh | 0.045 |
| CYP3a4-sub | 0.585 |
| CL | 16.084 |
| T12 | 0.085 |
| hERG | 0.123 |
| Ames | 0.065 |
| ROA | 0.224 |
| SkinSen | 0.821 |
| Carcinogencity | 0.064 |
| EI | 0.025 |
| Respiratory | 0.816 |
| NR-Aromatase | 0.083 |
| Antiviral | No |
| Prediction | 0.707708 |